RITM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Rithm Capital (RITM) is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a decent dividend/income profile and analysts remain generally positive, but the current technical setup is mixed-to-bearish, hedge funds are selling aggressively, and there is no strong proprietary buy signal today. Given the user's impatient profile and preference for a direct entry, this is a hold rather than an immediate buy.
Pre-market price is 9.26, up 0.22%, with the broader market also pre-market positive. Momentum is mixed: MACD histogram is above zero and expanding, which is constructive, but RSI_6 at 52.55 is neutral and does not show strong upside pressure. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, indicating the longer-term trend is still weak. Price is sitting near pivot resistance at 9.182 with nearby resistance at 9.347 and 9.448, while support is at 9.018 and 8.917. Short-term pattern data suggests limited near-term upside and a weak one-month profile.
["Analysts remain broadly bullish with multiple Outperform/Buy ratings.", "Citizens raised the price target to $13.50 and highlighted strong book value stability and attractive dividend yield.", "Wedbush said the quarterly dividend is covered more than 2x by Q1 EAD and called the shares an attractive entry point for income-oriented investors.", "The company continues to be viewed as a durable income play within the hybrid mortgage REIT space."]
["Hedge funds are selling, and the selling amount increased 284.34% over the last quarter.", "No recent news catalysts in the past week.", "Technical trend remains bearish due to SMA 200 above shorter averages.", "Pattern-based stock trend implies weak near-term performance, including a projected -5.65% over the next month.", "No recent congress trading data and no notable politician/influencer buying support."]
No usable latest-quarter financial snapshot was provided due to an error, so I cannot assess the most recent quarter directly. However, analyst commentary indicates Q1 EAD of 51 cents per share covering the 25-cent quarterly dividend by more than 2x, which supports the durability of the dividend and suggests solid income generation. The latest mentioned quarter season is Q1 2026.
Recent analyst trend is still positive overall, but price targets have been mixed-to-lower recently. Citizens raised its target to $13.50 and kept Outperform; Wedbush cut to $12.50 but maintained Outperform; Keefe Bruyette cut to $13 and kept Outperform; UBS lowered to $14.50 and kept Buy; Piper Sandler lowered to $14 and kept Overweight. Wall Street pros remain constructive on the stock’s income durability, book value stability, and valuation discount, but the sequence of target cuts suggests a more cautious near-term valuation stance. There is no recent politician or congress buying/selling data available.
